Glipizide and Aggrastat drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Glipizide (glipizide) and Aggrastat (tirofiban hydrochloride). Common drug interactions include haematocrit decreased among females and haematuria present among males.

The phase IV clinical study analyzes what interactions people have when they take Glipizide and Aggrastat. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Glipizide?

Glipizide has active ingredients of glipizide. It is often used in diabetes. eHealthMe is studying from 64,852 Glipizide users. Check the latest studies of Glipizide.

What is Aggrastat?

Aggrastat has active ingredients of tirofiban hydrochloride. eHealthMe is studying from 3,696 Aggrastat users. Check the latest studies of Aggrastat.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

14 people who take Glipizide and Aggrastat together, and have interactions are studied.

Glipizide and Aggrastat drug interactions.

What are the common drug interactions of Glipizide and Aggrastat, by gender? *:

female:

Haematocrit decreased
Haemoglobin decreased
Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
Haematoma (collection of blood outside the blood vessels)
Haematuria present (presence of blood in urine due to trauma)
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Injection site haemorrhage (bleeding from injection site)
Mitral valve incompetence (inefficient heart valve)
Pulmonary oedema (fluid accumulation in the lungs)

male:

Haematuria present (presence of blood in urine due to trauma)
Hypoglycaemia (deficiency of glucose in the bloodstream)
Peripheral neuropathy (damage to nerves of the peripheral nervous system)
Renal failure acute (rapid kidney dysfunction)
Sweating increased (excess sweating)
Thrombocytopenia (decrease of platelets in blood)
Pyrexia (fever)
Venous thrombosis deep limb (blood clot that forms in a vein deep in the limb)
Anuria (failure of the kidneys to produce urine)
Blood creatinine increased

What are the common drug interactions of Glipizide and Aggrastat, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Haematuria present (presence of blood in urine due to trauma)
Hypoglycaemia (deficiency of glucose in the bloodstream)
Pyrexia (fever)
Venous thrombosis deep limb (blood clot that forms in a vein deep in the limb)
Sweating increased (excess sweating)

60+:

Haematocrit decreased
Haemoglobin decreased
Rigors (an episode of shaking or exaggerated shivering)
Thrombocytopenia (decrease of platelets in blood)
Ventricular hypertrophy (enlargement of ventricles (lower chambers) in the heart)
Anuria (failure of the kidneys to produce urine)
Arterial disorder
Blood creatinine increased
Blood pressure decreased
Cardiac disorder

* Approximation only. Some reports may have incomplete information.

Do you take Glipizide and Aggrastat?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously